Startups
We are a Swiss microbiome biotherapeutics company, a spin-off from the Institute for Research in Biomedicine (IRB) in Bellinzona.
The patent protected Apy platform is a unique mechanism to generate protective immune response against enteric infections and to shape the intestinal microbiota in medical conditions with two applications:
1. ApyraVax® with the lead indication of Clostridium difficile infection
2. ApyraMed® with lead indications as enhancer in cancer immunotherapy and antibiotic-induced disbyosis.
Research experiments and preclinical trials are performed in the research lab hosted at IRB.
The company is looking for seed funding in order to move forward as a fully operational company into clinics with the main indications.
The patent protected Apy platform is a unique mechanism to generate protective immune response against enteric infections and to shape the intestinal microbiota in medical conditions with two applications:
1. ApyraVax® with the lead indication of Clostridium difficile infection
2. ApyraMed® with lead indications as enhancer in cancer immunotherapy and antibiotic-induced disbyosis.
Research experiments and preclinical trials are performed in the research lab hosted at IRB.
The company is looking for seed funding in order to move forward as a fully operational company into clinics with the main indications.
Overview
Location
Switzerland, Ticino, Bellinzona
Employees
1-10
Founded date
2018
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 10, 2020 | New leadership at Swiss startups | |
| Sep 10, 2020 | New leadership at Swiss startups | MV Biotherapeutics was established in 2018 as a spin-off from the Institute for Research in Biomedicine (IRB) in Bellinzona. He startup developed a patent-protected Apy platform to provide a unique mechanism to generate a protective immune ... |
| May 19, 2020 | Eleven Swiss start-ups on the virtual BIO Digital stage | BIO International Convention has transformed into BIO Digital to bring together players in the biotech industry to exchange ideas even in times when it is impossible to gather physically. From 8 - 12 June, more than 2300 companies from all ... |
| May 19, 2020 | Eleven Swiss start-ups on the virtual BIO Digital stage |
Reviews 0
FAQ about MV BioTherapeutics SA
When was MV BioTherapeutics SA founded?
MV BioTherapeutics SA was founded in 2018.
What has the press written about MV BioTherapeutics SA?
Parsers VC has collected 5 articles mentioning MV BioTherapeutics SA, among them “New leadership at Swiss startups” (Sep 10, 2020) and “New leadership at Swiss startups” (Sep 10, 2020).
Is MV BioTherapeutics SA still active?
Yes, MV BioTherapeutics SA is active; its latest activity on Parsers VC dates from May 23, 2022.